Professor Park Joon-sik of obstetrics and gynecology at Soonchunhyang University Bucheon Hospital announced on the 14th that ...

Rhian Butlin, 32, underwent an unnecessary hysterectomy after doctors thought a tumor on her ovary was cancerous.

Ovarian cancer affects over 22,000 women annually in the U.S., yet only 20% of cases are caught early. With no reliable ...

The electronic health record (EHR)–based symptom inventory identified symptom prevalence and associated comorbidities, but no ...

Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.

A woman underwent surgery to remove what she had been told was ovarian cancer. She was overjoyed when her results came back ...

I don't want to be explaining to my daughters why we've still failed to make progress on gynaecological cancers, writes Elise ...

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

Ovarian cancer, a leading cause of death among gynecological malignancies, has a poor prognosis and low 5-year survival rate, ...

Niraparib maintenance has a tolerable safety profile in patients with ovarian cancer, with hematologic toxicities being “the primary concern,” according to researchers. They e ...

A phase 3 trial of nemvaleukin alfa in with Keytruda for patients with platinum-resistant ovarian cancer will not continue on ...

In a live virtual event, Thomas C. Krivak, MD, reviewed the key studies of PARP inhibitor and bevacizumab maintenance in ...